Pfizer previously provided FY24 adjusted EPS guidance of $2.15-$2.35 and revenue guidance of $58.5B-$61.5B. Comments taken from the Goldman Sachs Annual Global Healthcare Conference.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Jefferies biotech analysts holds an analyst/industry conference call
- Relay teams with with Pfizer for RLY-2608/atirmociclib combo evaluation for BC
- Olema Oncology price target raised to $30 from $21 at Oppenheimer
- Here’s Why Novavax Stock (NVAX) Gained Over 21% Yesterday
- GSK (NYSE:GSK) Nosedives Amid Zantac Lawsuits Tsunami
Questions or Comments about the article? Write to editor@tipranks.com